Causal mutations in the gene coding for the enzyme SPTLC1 involved in lipid metabolism have been recently identified in juvenile ALS patients [35, 62], and TDP-43 is known to regulate transcription factors controlling lipid metabolism, especially cholesterol homeostasis [18, 30]. This evidence concerns the gene SPTLC1 and amyotrophic lateral sclerosis.